These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29174766)

  • 1. Brain choline in major depression: A review of the literature.
    Riley CA; Renshaw PF
    Psychiatry Res Neuroimaging; 2018 Jan; 271():142-153. PubMed ID: 29174766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarities of biochemical abnormalities between major depressive disorder and bipolar depression: a proton magnetic resonance spectroscopy study.
    Zhong S; Wang Y; Zhao G; Xiang Q; Ling X; Liu S; Huang L; Jia Y
    J Affect Disord; 2014 Oct; 168():380-6. PubMed ID: 25106035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered neurometabolism in major depressive disorder: A whole brain
    Kahl KG; Atalay S; Maudsley AA; Sheriff S; Cummings A; Frieling H; Schmitz B; Lanfermann H; Ding XQ
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jul; 101():109916. PubMed ID: 32169561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive regional neurochemical theory in depression: a protocol for the systematic review and meta-analysis of 1H-MRS studies in major depressive disorder.
    Drago T; O'Regan PW; Welaratne I; Rooney S; O'Callaghan A; Malkit M; Roman E; Levins KJ; Alexander L; Barry D; O'Hanlon E; O'Keane V; Roddy DW
    Syst Rev; 2018 Oct; 7(1):158. PubMed ID: 30309391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton spectroscopy study of the dorsolateral prefrontal cortex in youth with familial depression.
    Yang XR; Langevin LM; Jaworska N; Kirton A; Lebel RM; Harris AD; Jasaui Y; Wilkes TC; Sembo M; Swansburg R; MacMaster FP
    Psychiatry Clin Neurosci; 2016 Jul; 70(7):269-77. PubMed ID: 27059533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontal white matter biochemical abnormalities in first-episode, treatment-naive patients with major depressive disorder: a proton magnetic resonance spectroscopy study.
    Wang Y; Jia Y; Xu G; Ling X; Liu S; Huang L
    J Affect Disord; 2012 Feb; 136(3):620-6. PubMed ID: 22129769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis.
    Yildiz-Yesiloglu A; Ankerst DP
    Psychiatry Res; 2006 Jun; 147(1):1-25. PubMed ID: 16806850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
    Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain GABA levels across psychiatric disorders: A systematic literature review and meta-analysis of (1) H-MRS studies.
    Schür RR; Draisma LW; Wijnen JP; Boks MP; Koevoets MG; Joëls M; Klomp DW; Kahn RS; Vinkers CH
    Hum Brain Mapp; 2016 Sep; 37(9):3337-52. PubMed ID: 27145016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical correlates of rapid treatment response to electroconvulsive therapy in patients with major depression.
    Njau S; Joshi SH; Espinoza R; Leaver AM; Vasavada M; Marquina A; Woods RP; Narr KL
    J Psychiatry Neurosci; 2017 Jan; 42(1):6-16. PubMed ID: 27327561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The correlation between biochemical abnormalities in frontal white matter, hippocampus and serum thyroid hormone levels in first-episode patients with major depressive disorder.
    Jia Y; Zhong S; Wang Y; Liu T; Liao X; Huang L
    J Affect Disord; 2015 Jul; 180():162-9. PubMed ID: 25913802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: a review of the literature.
    Caverzasi E; Pichiecchio A; Poloni GU; Calligaro A; Pasin M; Palesi F; Castellazzi G; Pasquini M; Biondi M; Barale F; Bastianello S
    Funct Neurol; 2012; 27(1):13-22. PubMed ID: 22687162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic abnormality in the right dorsolateral prefrontal cortex in patients with obsessive-compulsive disorder: proton magnetic resonance spectroscopy.
    Park SE; Choi NG; Jeong GW
    Acta Neuropsychiatr; 2017 Jun; 29(3):164-169. PubMed ID: 27748207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive-compulsive disorder.
    Ljungberg M; Nilsson MKL; Melin K; Jönsson L; Carlsson A; Carlsson Å; Forssell-Aronsson E; Ivarsson T; Carlsson M; Starck G
    Acta Neuropsychiatr; 2017 Jun; 29(3):179-190. PubMed ID: 27772535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anterior cingulate cortex γ-aminobutyric acid deficits in youth with depression.
    Gabbay V; Bradley KA; Mao X; Ostrover R; Kang G; Shungu DC
    Transl Psychiatry; 2017 Aug; 7(8):e1216. PubMed ID: 28892070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents.
    Croarkin PE; Nakonezny PA; Wall CA; Murphy LL; Sampson SM; Frye MA; Port JD
    Psychiatry Res Neuroimaging; 2016 Jan; 247():25-33. PubMed ID: 26651598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of cortical glutathione in youth with depression.
    Freed RD; Hollenhorst CN; Weiduschat N; Mao X; Kang G; Shungu DC; Gabbay V
    Psychiatry Res Neuroimaging; 2017 Dec; 270():54-60. PubMed ID: 29078101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metabolic derangements examined using
    Pavlova I; Ruda-Kucerova J
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110808. PubMed ID: 37301420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant effect detected on proton magnetic resonance spectroscopy in drug-naïve female patients with first-episode major depression.
    Kaymak SU; Demir B; Oğuz KK; Sentürk S; Uluğ B
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):350-6. PubMed ID: 19566767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain proton magnetic resonance spectroscopy (1H-MRS) in Alzheimer's disease: changes after treatment with xanomeline, an M1 selective cholinergic agonist.
    Satlin A; Bodick N; Offen WW; Renshaw PF
    Am J Psychiatry; 1997 Oct; 154(10):1459-61. PubMed ID: 9326834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.